FiLM 2020: Programme


The programme for 2020 focuses on innovation in Pathology with sessions including:

Influencing Innovation in Pathology

There are challenges to the introduction of innovative practice in the NHS, such as time to implement and commissioning approval. Understand the ways in which the NHS is supporting the adoption of innovation and how we can, as pathology professionals, influence pathology innovation to a wide audience.  This session will include a global view of how we operationalise innovation and increase the pace of change to ensure that scientific developments translate into improvement in patient care with talks from leaders in the field, NHS improvement and NICE.

Innovating technology, pathology workforce and care pathways

Following on from the morning session, we start to delve into ideas that we can put into practice.

We will hear from the Accelerated Access team to understand how the Accelerated Access Collaborative brings together industry, government and the NHS to enable rapid uptake of innovation to the benefit of patient care. 

Path Links and Nottingham University Hospitals will present how they have collaborated using digital pathology to deliver breast pathology services across a rural DGH multi-hospital pathology network. The technological, infrastructure, organisational and cultural barriers to developing a new service model and how they can be overcome will also be explored. 

With recent workforce reports indicating that only 3% of histopathology departments have enough Consultant staff, coupled with rising service demand and insufficient trainees, Jo Martin will update on the current clinical workforce situation and present on innovative solutions being adopted to overcome staffing shortages.

Getting it right first time

The GIRFT project aims to improve patient pathways and clinical outcomes, reduce unwarranted variation and enhance the experiences of patients. 

Following the successful and well received presentation from the team at FiLM 2019, they are back with the preliminary findings from the GIRFT questionnaires that have been submitted by Trusts throughout the year. The panel discussion offers a valuable opportunity for audience feedback and debate with GIRFT team members.

Innovation in clinical care from theory to practice

This session presents examples of where and how innovation has been successfully brought into practice.

Pre-eclampsia is a potential serious complication of pregnancy usually requiring hospital admission. Hear how adoption of PIGF, a marker of placental angiogenesis, is undergoing rapid implementation across the NHS to help rule out the diagnosis of pre-eclampsia in pregnancy and enable continuing community monitoring.

High sensitive troponin analysis as part of a rapid algorithm for the assessment of chest pain and in conjunction with clinical decision making can reduce unnecessary time to discharge whilst enabling appropriate and timely treatment of patients suspected of having myocardial infarction. Hear how effective clinical leadership and team working are vital in embedding a rapid assessment clinical pathway for chest pain

Many patients are lost to follow up, there are instances whereby the required follow up is a laboratory test. Learn how the laboratory infrastructure together with state of the art app development can enable the recall of patients with conditions such as gestational diabetes and gout. The routine recall for repeat blood tests can benefit both patient care whilst saving scarce NHS resource.

Pathology Networks and Learning Lessons

David Wells, Head of Pathology Consolidation, NHS Improvement will update on the progress and achievements made as Trusts move toward 29 pathology networks across England. This isn’t something new to other devolved nations within the UK and Scotland,  Wales and Northern Ireland representatives will also present the progress of their networks,  the challenges faced and the key enablers to success.
There will be a particular focus on setting up a POCT network within Wales. 

Big data and how it is improving patient care

Gain an understanding or how laboratory Big Data can assist predictions and influence decisions about the health of a country, region or an individual.

Following the success of the Open Prescribing database, which enables primary care clinicians to understand and address variation in prescribing practice, Open Pathology will present Software tools to assist clinical users of pathology to assess and optimise service demand by evaluating variations in test requesting practice.

This session will also cover talks on Artificial intelligence and what it could mean to Pathology and Medicine from improvement in computerized image analysis and machine learning techniques that are being applied to digitized tissue histopathology, to clinical decision support artificial intelligence algorithms being used in biochemistry. 

© Copyright The Association for Clinical Biochemistry and Laboratory Medicine
The Association for Clinical Biochemistry and Laboratory Medicine, 130-132 Tooley Street LONDON SE1 2TU
Tel: 020 7403 8001 Fax: 020 7403 8006